Skip to main content
Premium Trial:

Request an Annual Quote

DiaGenic Taps Ferrer InCode as Distributor

NEW YORK (GenomeWeb News) – Norwegian gene expression-based diagnostics company DiaGenic said today that it has signed up Ferrer InCode to distribute its Alzheimer's disease test in certain countries in Europe and Latin America.

Barcelona, Spain-based Ferrer InCode will distribute the ADtect test for early diagnosis of Alzheimer's disease in Germany, Belgium, France, the Netherlands, Italy, Spain, and Portugal, as well as in Latin American nations.

A subsidiary of Grupo Ferrer International, Ferrer InCode is focused on offering personalized medicine products including prognostic and predictive technologies based on genomics, proteomics, metabolomics, and bioinformatics.

"Early detection enables subsequent early initiation of active management strategies, which may preserve the patients' level of function for longer and increases the chances of delaying the progression of the disease," DiaGenic CEO Erik Christensen said in a statement.

"Current evidence suggests that pharmacological treatments and caregiver interventions can delay entry into nursing homes, thus reducing healthcare costs," Christensen added. "However, these cost savings are not being realized because many patients with Alzheimer's disease are either not diagnosed or diagnosed at a late stage of the disease."

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.